9 pharma leaders sound ‘alarm bells’ on biotech’s decline in Europe
Frustrated by a slump that’s seen Europe lose ground to the U.S. and China, several top drugmakers are calling for speedier clinical trials, intellectual property protections and “fiscal flexibility.”
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.